Monopar Therapeutics

MNPRNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$798.595 M

$119.21 -0.83%

Close of 7 Aug 2026

Revenue

$0.00

#3658 by revenue

Earnings

-$13.7M

Loss-making

Shares outstanding

6,692,140

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#175Aclaris TherapeuticsACRS$825.4M
#176Climb BioCLYM$801.7M
#177Monopar TherapeuticsMNPR$798.6M
#178Bright Minds BiosciencesDRUG$778.4M
#179Pharming GroupPHAR$773.3M

Where these numbers come from

Share counts and financials for Monopar Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.